Bennani, B. Et Al. 2007. Combined drug design of potential Mycobacterium tuberculosis and HIV-1 inhibitors: 3′,4′-di-substituted -4′H-spiro [isothiochromene-3,5′-isoxazol]-4(1H)-one. Arkivoc , vol.2007, no.16 , 19-40.

Bennani, B., Kerbal, A., Daoudi, M., Baba, B. F., Al Houari, G., Jalbout, A. F., ... Mimouni, M.(2007). Combined drug design of potential Mycobacterium tuberculosis and HIV-1 inhibitors: 3′,4′-di-substituted -4′H-spiro [isothiochromene-3,5′-isoxazol]-4(1H)-one. Arkivoc , vol.2007, no.16, 19-40.

Bennani, B. Et Al. "Combined drug design of potential Mycobacterium tuberculosis and HIV-1 inhibitors: 3′,4′-di-substituted -4′H-spiro [isothiochromene-3,5′-isoxazol]-4(1H)-one," Arkivoc , vol.2007, no.16, 19-40, 2007

Bennani, B. Et Al. "Combined drug design of potential Mycobacterium tuberculosis and HIV-1 inhibitors: 3′,4′-di-substituted -4′H-spiro [isothiochromene-3,5′-isoxazol]-4(1H)-one." Arkivoc , vol.2007, no.16, pp.19-40, 2007

Bennani, B. Et Al. (2007) . "Combined drug design of potential Mycobacterium tuberculosis and HIV-1 inhibitors: 3′,4′-di-substituted -4′H-spiro [isothiochromene-3,5′-isoxazol]-4(1H)-one." Arkivoc , vol.2007, no.16, pp.19-40.

@article{article, author={B. Bennani Et Al. }, title={Combined drug design of potential Mycobacterium tuberculosis and HIV-1 inhibitors: 3′,4′-di-substituted -4′H-spiro [isothiochromene-3,5′-isoxazol]-4(1H)-one}, journal={Arkivoc}, year=2007, pages={19-40} }